Zealand Pharma AS (ZLDPF)
135.65
+2.24
(+1.68%)
USD |
OTCM |
Sep 20, 16:00
Zealand Pharma Price: 135.65 for Sept. 20, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 20, 2024 | 135.65 | 135.65 | 135.65 | 135.65 | 741.00 |
| Sep 19, 2024 | 133.41 | 133.41 | 133.41 | 133.41 | 0.000 |
| Sep 18, 2024 | 133.41 | 133.41 | 133.41 | 133.41 | 153.00 |
| Sep 17, 2024 | 134.71 | 134.71 | 134.71 | 134.71 | 331.00 |
| Sep 16, 2024 | 135.89 | 135.89 | 134.71 | 134.71 | 505.00 |
| Sep 13, 2024 | 135.74 | 136.76 | 135.47 | 136.76 | 737.00 |
| Sep 12, 2024 | 130.81 | 130.81 | 130.81 | 130.81 | 506.00 |
| Sep 11, 2024 | 131.99 | 131.99 | 131.99 | 131.99 | 114.00 |
| Sep 10, 2024 | 125.75 | 125.75 | 125.75 | 125.75 | 132.00 |
| Sep 09, 2024 | 128.00 | 128.00 | 121.51 | 125.00 | 1550.00 |
| Sep 06, 2024 | 125.75 | 126.53 | 125.75 | 126.53 | 291.00 |
| Sep 05, 2024 | 121.50 | 124.08 | 120.00 | 124.08 | 2344.00 |
| Sep 04, 2024 | 125.00 | 128.75 | 125.00 | 128.00 | 5771.00 |
| Sep 03, 2024 | 126.00 | 126.00 | 126.00 | 126.00 | 0.000 |
| Aug 30, 2024 | 126.00 | 126.00 | 126.00 | 126.00 | 0.000 |
| Aug 29, 2024 | 126.00 | 126.00 | 126.00 | 126.00 | 0.000 |
| Aug 28, 2024 | 126.00 | 126.00 | 126.00 | 126.00 | 176.00 |
| Aug 27, 2024 | 127.50 | 127.50 | 127.50 | 127.50 | 0.000 |
| Aug 26, 2024 | 127.90 | 127.90 | 127.50 | 127.50 | 452.00 |
| Aug 23, 2024 | 130.72 | 130.72 | 130.72 | 130.72 | 211.00 |
| Aug 22, 2024 | 132.25 | 132.25 | 132.25 | 132.25 | 237.00 |
| Aug 21, 2024 | 135.00 | 135.00 | 127.90 | 133.33 | 1304.00 |
| Aug 20, 2024 | 134.00 | 134.00 | 132.47 | 132.47 | 1232.00 |
| Aug 19, 2024 | 133.23 | 134.60 | 133.23 | 134.60 | 1185.00 |
| Aug 16, 2024 | 141.74 | 141.74 | 141.74 | 141.74 | 543.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
11.14
Minimum
May 11 2022
141.74
Maximum
Aug 16 2024
41.91
Average
33.10
Median
Nov 14 2019
Price Benchmarks
| Novo Nordisk AS | 127.51 |
| Eli Lilly and Co | 921.49 |
| Altimmune Inc | 7.79 |
| Genmab AS | 25.53 |
| Viking Therapeutics Inc | 70.54 |
Price Related Metrics
| PS Ratio | 153.63 |
| Price to Book Value | 7.134 |
| Earnings Yield | -1.25% |
| Market Cap | 9.622B |